Development of optimised microdystrophin gene therapy to mitigate transgene triggered immune adverse events

£2.46M GBP

Funder	Medical Research Council
Recipient Organization	University College London
Country	Unknown
Start Date	Sep 30, 2024
End Date	Dec 31, 2025
Duration	457 days
Number of Grantees	1
Roles	Award Holder
Data Source	UKRI Gateway to Research
Grant ID	`81`

Grant Description

Abstracts are not currently available in GtR for all funded research.

This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.